期刊文献+

Identification the main molecular mechanism of AT1R Non-desensitization

原文传递
导出
摘要 Angiotensin II Type 1 Receptor Autoantibodies(AT1-AA)as a functional receptor activator can persistently activate Angiotensin II Type 1 Receptor(AT1R)by causing AT1R non-desensitization which is one of the important pathogenesis of preeclampsia(PE).However,the molecular mechanisms of AT1-AA results AT1R non-desensitization remain unknown.In order to explore the background molecular mechanisms of AT1R non-desensitization induced by AT1-AA,we construct dynamical models which are composed of control model(based on the body of healthy pregnant women)and experimental group models(based on the body of pregnant women with PE)in this paper.We also consider the effect of membrane fluidity on the reaction when building the dynamical models.In the experiment group models,we establish two models that caused AT1R non-desensitization:endocytosis disorder model and conformational change model.We write C++and MATLAB programs to do the data fitting.By comparing the data fitting results and analyzing the images of models and corresponding Bayesian information criterion(BIC)values,we conclude that conformational changes may be the key molecular mechanism of AT1R non-desensitization.
出处 《International Journal of Biomathematics》 SCIE 2020年第6期213-229,共17页 生物数学学报(英文版)
  • 相关文献

参考文献1

二级参考文献17

  • 1Anton L, Brosnihan KB. Systemic and uteroplacental renin-angiotensin sys- tem in normal and preeclamptic pregnancies. Ther Adv Cardiovasc Dis 2008, 2: 349-362.
  • 2Pipkin FB, Baker PN. Angiotensin II has depressor effects in pregnant and nonpregnant women. Hypertension 1997, 30: 1247-1252.
  • 3Shah DM. Preeclampsia: new insights. Curt Opin Nephrol Hypertens 2007, 16: 213-220.
  • 4Anton L, Merrill DC, Neves LA, Diz DI, Corthorn J, Valdes G, Stovall K, et al. The uterine placental bed renin-angiotensin system in normal and pre- eclamptic pregnancy. Endocrinology 2009, 150: 4316-4325.
  • 5Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jipner A, Baur E, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999, 103: 945-952.
  • 6LaMarca B, Wallace K, Granger J. Role of angiotensin II type I receptor ag- onistic autoantibodies (AT1-AA) in preeclampsia. Curr Opin Pharmacol 2011, 11: 175-179.
  • 7Brewer J, Liu R, Lu Y, Scott J, Wallace K, Wallukat G, Moseley J, et al. Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy. Hypertension 2013, 62: 886-892.
  • 8Dechend R, Miiller DN, Wallukat G, Homuth V, Krause M, Dudenhausen J, Luft FC. AT1 receptor agonistic antibodies, hypertension, and preeclampsia. Sernin Nephrol 2004, 24: 571-579.
  • 9Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, Hicks MJ, et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 2008, 14: 855-862.
  • 10Wenzel K, Rajakumar A, Haase H, Geusens N, Hubner N, Schulz H, Brewer J, et al. Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension 2011, 58: 77-84.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部